ArticleBeyoglu eye journal2025
Anxiety Levels Before Intravitreal Injections.
Article in Beyoglu eye journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: In our study, using amsterdam pre-operative anxiety and information scale (APAIS) and visual analog scale anxiety (VASA) analyze the patient's anxiety level about intraocular injection therapy and assess possible risk factors for these levels of anxiety in relation to the patient's sociodemographic, disease, and treatment characteristics. Methods: Three hundred sixty-nine patients who received intravitreal ranibizumab, aflibercept, bevacizumab, and dexamethasone implants were included in the study. To measure the level of anxiety, APAIS questionnaire and VASA were used. APAIS and VASA were evaluated according to age, sex, indication for the injection, injection drug, previous injection numbers, and lens status in the study eye. Results: About 15.4% of the patients participating in the study had VASA ≥6. The APAIS anxiety component score of 43.9% of the patients was found to be ≥11. Total information requests were found to be ≥5 in 48.7% of the patients. There was a significant negative correlation between VASA, APAIS, and patient age (spearman r=-0.25, p=0.004, r=-0.22, p=0.001). A significant negative correlation was found between the number of previous injections and anxiety levels measured by VASA (spearman r=-0.35, p=0.02), as well as between the number of previous injections and APAIS scores (anxiety levels and total information request) (spearman r=-0.32, p=0.03). There was a no significant difference between VASA, APAIS, and patient sex (p<0.05). A higher level of anxiety measured by VASA and APAIS has been shown in patients who have not had cataract surgery before, compared to those who have undergone cataract surgery (p<0.05). Conclusion: The study underscores the importance of improving patient information and conducting further research to alleviate stress levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.